Bradford Crutchfield
Vice President, Bio-Rad Laboratories.
Companies
- 10X GenomicsChief Commercial Officer Sep 11, 2019 to May 25, 20221
- Bio-Rad LaboratoriesVice President Feb 3, 2004 to Jun 11, 20142
- NanoString TechnologiesBoard member Jun 25, 2013 to Jan 3, 20143
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
10X Genomics TXG97,237 shares4$6.8M at $69.95May 23, 2022
Bio-Rad Laboratories BIO5,332 shares5$1.9M at $354.24Jun 10, 2014
As of each latest filing. The line shows shares held over time.
Recent filings
- May 23, 2022Sold 286 shares at $48.76 of 10X Genomics4
- May 13, 2022Bought 158 shares at $40.49 of 10X Genomics6
- Feb 22, 2022Sold 288 shares at $78.60 of 10X Genomics7
- Feb 15, 2022Sold 17,000 shares at $95.13 of 10X Genomics8
- Feb 15, 2022Exercised options 17,000 shares at $1.16 of 10X Genomics8
- Jan 12, 2022Sold 3 shares at $125.00 of 10X Genomics9
- Jan 12, 2022Sold 100 shares at $124.44 of 10X Genomics9
- Jan 12, 2022Sold 100 shares at $123.53 of 10X Genomics9
- Jan 12, 2022Sold 100 shares at $122.94 of 10X Genomics9
- Jan 12, 2022Sold 3,200 shares at $121.77 of 10X Genomics9
- Jan 12, 2022Sold 1,100 shares at $120.93 of 10X Genomics9
- Jan 12, 2022Sold 1,017 shares at $119.28 of 10X Genomics9
- Jan 12, 2022Sold 5,185 shares at $118.32 of 10X Genomics9
- Jan 12, 2022Sold 6,195 shares at $117.53 of 10X Genomics9
- Jan 12, 2022Exercised options 17,000 shares at $1.16 of 10X Genomics9
- Dec 21, 2021Exercised options 49,910 shares at $5.04 of 10X Genomics10
- Dec 21, 2021Exercised options 4,688 shares at $1.20 of 10X Genomics10
- Dec 13, 2021Sold 100 shares at $142.47 of 10X Genomics11
- Dec 13, 2021Sold 800 shares at $141.31 of 10X Genomics11
- Dec 13, 2021Sold 1,701 shares at $140.38 of 10X Genomics11
- Dec 13, 2021Sold 9,599 shares at $139.52 of 10X Genomics11
- Dec 13, 2021Sold 3,235 shares at $138.60 of 10X Genomics11
- Dec 13, 2021Sold 1,565 shares at $137.63 of 10X Genomics11
- Dec 13, 2021Exercised options 17,000 shares at $1.16 of 10X Genomics11
- Nov 22, 2021Sold 281 shares at $148.38 of 10X Genomics12
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARBio-Rad Laboratories, Vice President
- 3
- 4
- 5
- 6SEC EDGARForm 4 filed May 17, 2022
- 7SEC EDGARForm 4 filed Feb 24, 2022
- 8SEC EDGARForm 4 filed Feb 17, 2022
- 9SEC EDGARForm 4 filed Jan 14, 2022
- 10SEC EDGARForm 4 filed Dec 23, 2021
- 11SEC EDGARForm 4 filed Dec 15, 2021
- 12SEC EDGARForm 4 filed Nov 24, 2021